ArticleOpen forum infectious diseases2023

Antibody Response After Third Vaccination With mRNA-1273 or BNT162b2: Extension of a Randomized Controlled SARS-CoV-2 Noninferiority Vaccine Trial in Patients With Different Levels of Immunosuppression (COVERALL-2).

Alexandra Griessbach et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.